저칼륨혈증과 횡문근융해증으로 발현한 원발성 알도스테론증 1예
Primary Aldosteronism Presenting as Hypokalemia and Rhabdomyolysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Primary aldosteronism is one of the most common cause of secondary hypertension and can be accompanied with hypokalemia. Rhabdomyolysis with hypokalemia in primary aldosteronism has been rarely reported. We describe a patient of primary aldosteronism who presented with limb-girdle type weakness. (Korean J Clin Neurophysiol 2016;18:21-24)
Abstract
Primary aldosteronism is one of the most common cause of secondary hypertension and can be accompanied with hypokalemia. Rhabdomyolysis with hypokalemia in primary aldosteronism has been rarely reported. We describe a patient of primary aldosteronism who presented with limb-girdle type weakness. (Korean J Clin Neurophysiol 2016;18:21-24)
참고문헌 (10)
- Funder JW, "Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline", J Clin Endocrinol Metab, 93, pp.3266~3281 (2008)
- Omura M, "Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism", Hypertens Res, 29, pp.883~889 (2006)
- 이종하, "Hypokalemia-Induced Rhabdomyolysis by Primary Aldosteronism Coexistent With Sporadic Inclusion Body Myositis", Annals of Rehabilitation Medicine, 39(5), pp.826~832 (2015), 대한재활의학회
- 박웅, "횡문근융해증을 동반한 원발성 알도스테론증 1예", Kidney Research and Clinical Practice, 24(5), pp.845~850 (2005), 대한신장학회
- 윤원재, "한국에서의 췌장의 낭성 종양", 대한내과학회지, 70(3), pp.261~267 (2006), 대한내과학회
- Kim HI, "A case of primary aldosteronism accompanied by hypokalemic rhabdomyolysis", Yeungnam Univ J Med, 29, pp.113~117 (2012)
- Chao CT, "Diagnosis and management of primary aldosteronism: an updated review", Ann Med, 45, pp.375~383 (2013)
- Zimmerman JL, "Rhabdomyolysis", Chest, 144, pp.1058~1065 (2013)
- Ellison DH, "Thiazide effects and adverse effects: Insights from molecular genetics", Hypertension, 54, pp.196~202 (2009)
- Furberg CD, "The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic", J Am Med Assoc, 288, pp.2981~2997 (2002)